The HECTD3 E3 ubiquitin ligase facilitates cancer cell survival by promoting K63-linked polyubiquitination of caspase-8

Cell Death and Disease

Volumn 4, Issue 11, 2013, Pages

  Li, Y ^a,b   Kong, Y ^a   Zhou, Z ^a   Chen, H ^c   Wang, Z ^a   Hsieh, Y C ^d   Zhao, D ^d   Zhi, X ^d   Huang, J ^e   Zhang, J ^c   Li, H ^c,f   Chen, C ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b CANCER HOSPITAL   (China)

^c WADSWORTH CENTER   (United States)

^d ALBANY MEDICAL COLLEGE   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Apoptosis; Breast cancer; Caspase 8; HECTD3; Ubiquitination

Indexed keywords

CASPASE 8; CYSTEINE; HECTD3; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL SURVIVAL; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

APOPTOSIS; CASPASE 8; CELL LINE; CELL SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; PROTEIN BINDING; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84889608979     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.464     Document Type: Article

References (47)

1. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999; 68: 383-424
2. Riedl SJ, Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 2004; 5: 897-907
3. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-And TNF receptor-induced cell death. Cell 1996; 85: 803-815
4. Chang DW, Xing Z, Capacio VL, Peter ME, Yang X. Interdimer processing mechanism of procaspase-8 activation. Embo J 2003; 22: 4132-4142
5. Kurokawa M, Kornbluth S. Caspases and kinases in a death grip. Cell 2009; 138: 838-854
6. Riedl SJ, Renatus M, Schwarzenbacher R, Zhou Q, Sun C, Fesik SW, et al. Structural basis for the inhibition of caspase-3 by XIAP. Cell 2001; 104: 791-800
7. Chai J, Shiozaki E, Srinivasula SM, Wu Q, Datta P, Alnemri ES, et al. Structural basis of caspase-7 inhibition by XIAP. Cell 2001; 104: 769-780
8. Shiozaki EN, Chai J, Rigotti DJ, Riedl SJ, Li P, Srinivasula SM, et al. Mechanism of XIAP-mediated inhibition of caspase-9. Mol Cell 2003; 11: 519-527
9. Huang H, Joazeiro CA, Bonfoco E, Kamada S, Leverson JD, Hunter T. The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. J Biol Chem 2000; 275: 26661-26664
10. Choi YE, Butterworth M, Malladi S, Duckett CS, Cohen GM, Bratton SB. The E3 ubiquitin ligase cIAP1 binds and ubiquitinates caspase-3 and-7 via unique mechanisms at distinct steps in their processing. J Biol Chem 2009; 284: 12772-12782
11. Jin Z, Li Y, Pitti R, Lawrence D, Pham VC, Lill JR, et al. Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell 2009; 137: 721-735
12. Peng C, Cho YY, Zhu F, Zhang J, Wen W, Xu Y, et al. Phosphorylation of caspase-8 (Thr-263) by ribosomal S6 kinase 2 (RSK2) mediates caspase-8 ubiquitination and stability. J Biol Chem 2011; 286: 6946-6954
13. Christian PA, Fiandalo MV, Schwarze SR. Possible role of death receptor-mediated apoptosis by the E3 ubiquitin ligases Siah2 and POSH. Mol Cancer 2011; 10: 57
14. Gonzalvez F, Lawrence D, Yang B, Yee S, Pitti R, Marsters S, et al. TRAF2 Sets a threshold for extrinsic apoptosis by tagging caspase-8 with a ubiquitin shutoff timer. Mol Cell 2012; 48: 888-899
15. Thorpe JA, Christian PA, Schwarze SR. Proteasome inhibition blocks caspase-8 degradation and sensitizes prostate cancer cells to death receptor-mediated apoptosis. Prostate 2008; 68: 200-209
16. Fiandalo MV, Schwarze SR, Kyprianou N. Proteasomal regulation of caspase-8 in cancer cell apoptosis. Apoptosis 2013; 18: 766-776
17. Broemer M, Meier P. Ubiquitin-mediated regulation of apoptosis. Trends Cell Biol 2009; 19: 130-140
18. McManus DC, Lefebvre CA, Cherton-Horvat G, St-Jean M, Kandimalla ER, Agrawal S, et al. Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics. Oncogene 2004; 23: 8105-8117
19. Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, Garg P, et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 2007; 131: 669-681
20. Bernassola F, Karin M, Ciechanover A, Melino G. The HECT family of E3 ubiquitin ligases: Multiple players in cancer development. Cancer Cell 2008; 14: 10-21
21. Garcia-Gonzalo FR, Rosa JL. The HERC proteins: Functional and evolutionary insights. Cell Mol Life Sci 2005; 62: 1826-1838
22. Chen C, Matesic LE. The Nedd4-like family of E3 ubiquitin ligases and cancer. Cancer Metastasis Rev 2007; 26: 587-604
23. Li Y, Zhou Z, Chen C. WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis. Cell Death Differ 2008; 15: 1941-1951
24. Zhong Q, Gao W, Du F, Wang X. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 2005; 121: 1085-1095
25. Pal M, Varga K, Nagy O, Deak P. Characterization of the Apc10/Doc1 subunit of the anaphase promoting complex in Drosophila melanogaster. Acta Biol Hung 2007; 58(Suppl): 51-64
26. Kaustov L, Lukin J, Lemak A, Duan S, Ho M, Doherty R, et al. The conserved CPH domains of Cul7 and PARC are protein-protein interaction modules that bind the tetramerization domain of p53. J Biol Chem 2007; 282: 11300-11307
27. Yu J, Lan J, Zhu Y, Li X, Lai X, Xue Y, et al. The E3 ubiquitin ligase HECTD3 regulates ubiquitination and degradation of Tara. Biochem Biophys Res Commun 2008; 367: 805-812
28. Zhang L, Kang L, Bond W, Zhang N. Interaction between syntaxin 8 and HECTd3, a HECT domain ligase. Cell Mol Neurobiol 2009; 29: 115-121
29. Li Y, Chen X, Wang Z, Zhao D, Chen H, Chen W, et al. The HECTD3 E3 Ubiquitin Ligase Suppresses Cisplatin-Induced Apoptosis via Stabilizing MALT1. Neoplasia 2013; 15: 39-48
30. Kawadler H, Gantz MA, Riley JL, Yang X. The paracaspase MALT1 controls caspase-8 activation during lymphocyte proliferation. Mol Cell 2008; 31: 415-421
31. Newton K, Matsumoto ML, Wertz IE, Kirkpatrick DS, Lill JR, Tan J, et al. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell 2008; 134: 668-678
32. Huang L, Kinnucan E, Wang G, Beaudenon S, Howley PM, Huibregtse JM, et al. Structure of an E6AP-UbcH7 complex: Insights into ubiquitination by the E2-E3 enzyme cascade. Science 1999; 286: 1321-1326
33. Medema JP, Scaffidi C, Krammer PH, Peter ME. Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex. J Biol Chem 1998; 273: 3388-3393
34. Oberst A, Pop C, Tremblay AG, Blais V, Denault JB, Salvesen GS, et al. Inducible dimerization and inducible cleavage reveal a requirement for both processes in caspase-8 activation. J Biol Chem 2010; 285: 16632-16642
35. Cohen GM. Caspases: The executioners of apoptosis. Biochem J 1997; 326(Pt 1): 1-16
36. Dias DC, Dolios G, Wang R, Pan ZQ. CUL7: A DOC domain-containing cullin selectively binds Skp1.Fbx29 to form an SCF-like complex. Proc Natl Acad Sci USA 2002; 99: 16601-16606
37. Passmore LA, McCormack EA, Au SW, Paul A, Willison KR, Harper JW, et al. Doc1 mediates the activity of the anaphase-promoting complex by contributing to substrate recognition. Embo J 2003; 22: 786-796
38. Valmiki MG, Ramos JW. Death effector domain-containing proteins. Cell Mol Life Sci 2009; 66: 814-830
39. Mace PD, Shirley S, Day CL. Assembling the building blocks: Structure and function of inhibitor of apoptosis proteins. Cell Death Differ 2010; 17: 46-53
40. Ditzel M, Broemer M, Tenev T, Bolduc C, Lee TV, Rigbolt KT, et al. Inactivation of effector caspases through nondegradative polyubiquitylation. Mol Cell 2008; 32: 540-553
41. Tomar D, Prajapati P, Sripada L, Singh K, Singh R, Singh AK, et al. TRIM13 regulates caspase-8 ubiquitination, translocation to autophagosomes and activation during ER stress induced cell death. Biochim Biophys Acta 2013; 1833: 3134-3144
42. Thoreau V, Berges T, Callebaut I, Guillier-Gencik Z, Gressin L, Bernheim A, et al. Molecular cloning, expression analysis, and chromosomal localization of human syntaxin 8 (STX8). Biochem Biophys Res Commun 1999; 257: 577-583
43. Zeng W, Xu M, Liu S, Sun L, Chen ZJ. Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3. Mol Cell 2009; 36: 315-325
44. Chen C, Zhou Z, Ross JS, Zhou W, Dong JT. The amplified WWP1 gene is a potential molecular target in breast cancer. Int J Cancer 2007; 121: 2834-2841
45. Chen C, Sun X, Guo P, Dong XY, Sethi P, Zhou W, et al. Ubiquitin E3 ligase WWP1 as an oncogenic factor in human prostate cancer. Oncogene 2007; 26: 2386-2394
46. Mohsin SK, Weiss H, Havighurst T, Clark GM, Berardo M, Roanh le D, et al. Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: A validation study. Mod Pathol 2004; 17: 1545-1554
47. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007; 23: 2947-2948